Subgroup analysis of DCIS populations in multiple studies showed a trend to benefit with aromatase inhibitor treatment.
← all excerpts
Breast Ductal Carcinoma <i>In Situ</i>: A Literature Review of Adjuvant Hormonal Therapy.
1
—
—
Subgroup analysis of DCIS populations in multiple studies showed a trend to benefit with aromatase inhibitor treatment.